These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 9316884
1. Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases. Klein T, Reutter F, Schweer H, Seyberth HW, Nüsing RM. J Pharmacol Exp Ther; 1997 Sep; 282(3):1658-65. PubMed ID: 9316884 [Abstract] [Full Text] [Related]
2. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. Schweer H, Watzer B, Seyberth HW, Nüsing RM. J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285 [Abstract] [Full Text] [Related]
3. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism. Klein T, Neuhaus K, Reutter F, Nüsing RM. Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387 [Abstract] [Full Text] [Related]
4. Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. Praticó D, FitzGerald GA. J Biol Chem; 1996 Apr 12; 271(15):8919-24. PubMed ID: 8621535 [Abstract] [Full Text] [Related]
5. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man. Bachi A, Brambilla R, Fanelli R, Bianchi R, Zuccato E, Chiabrando C. Br J Pharmacol; 1997 Aug 12; 121(8):1770-4. PubMed ID: 9283716 [Abstract] [Full Text] [Related]
7. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor. Kearney D, Byrne A, Crean P, Cox D, Fitzgerald DJ. J Am Coll Cardiol; 2004 Feb 18; 43(4):526-31. PubMed ID: 14975458 [Abstract] [Full Text] [Related]
8. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms. Praticò D, Smyth EM, Violi F, FitzGerald GA. J Biol Chem; 1996 Jun 21; 271(25):14916-24. PubMed ID: 8663015 [Abstract] [Full Text] [Related]
9. Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor. Smedman A, Vessby B, Basu S. Clin Sci (Lond); 2004 Jan 21; 106(1):67-73. PubMed ID: 12956622 [Abstract] [Full Text] [Related]
10. The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Minuz P, Andrioli G, Degan M, Gaino S, Ortolani R, Tommasoli R, Zuliani V, Lechi A, Lechi C. Arterioscler Thromb Vasc Biol; 1998 Aug 21; 18(8):1248-56. PubMed ID: 9714131 [Abstract] [Full Text] [Related]
11. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. Giuliano F, Warner TD. J Pharmacol Exp Ther; 2002 Dec 21; 303(3):1001-6. PubMed ID: 12438520 [Abstract] [Full Text] [Related]
12. Cellular mechanisms involved during oxytocin-induced prostaglandin F2alpha production in endometrial epithelial cells in vitro: role of cyclooxygenase-2. Asselin E, Drolet P, Fortier MA. Endocrinology; 1997 Nov 21; 138(11):4798-805. PubMed ID: 9348208 [Abstract] [Full Text] [Related]
13. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. Minghetti L, Greco A, Cardone F, Puopolo M, Ladogana A, Almonti S, Cunningham C, Perry VH, Pocchiari M, Levi G. J Neuropathol Exp Neurol; 2000 Oct 21; 59(10):866-71. PubMed ID: 11079776 [Abstract] [Full Text] [Related]
14. Formation of 8-iso-prostaglandin F2 alpha by human platelets. Pratico D, Reilly M, Lawson J, Delanty N, FitzGerald GA. Agents Actions Suppl; 1995 Oct 21; 45():27-31. PubMed ID: 7717189 [Abstract] [Full Text] [Related]
15. Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release. Fukunaga M, Yura T, Badr KF. J Cardiovasc Pharmacol; 1995 Oct 21; 26 Suppl 3():S51-2. PubMed ID: 8587462 [Abstract] [Full Text] [Related]
16. Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha. Chiabrando C, Valagussa A, Rivalta C, Durand T, Guy A, Zuccato E, Villa P, Rossi JC, Fanelli R. J Biol Chem; 1999 Jan 15; 274(3):1313-9. PubMed ID: 9880501 [Abstract] [Full Text] [Related]
17. Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ischemia-reperfusion. Favreau F, Petit-Paris I, Hauet T, Dutheil D, Papet Y, Mauco G, Tallineau C. Free Radic Biol Med; 2004 Apr 15; 36(8):1034-42. PubMed ID: 15059644 [Abstract] [Full Text] [Related]
19. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Morrow JD, Zackert WE, Yang JP, Kurhts EH, Callewaert D, Dworski R, Kanai K, Taber D, Moore K, Oates JA, Roberts LJ. Anal Biochem; 1999 May 01; 269(2):326-31. PubMed ID: 10222005 [Abstract] [Full Text] [Related]
20. IPF2alpha-I: an index of lipid peroxidation in humans. Praticò D, Barry OP, Lawson JA, Adiyaman M, Hwang SW, Khanapure SP, Iuliano L, Rokach J, FitzGerald GA. Proc Natl Acad Sci U S A; 1998 Mar 31; 95(7):3449-54. PubMed ID: 9520386 [Abstract] [Full Text] [Related] Page: [Next] [New Search]